PROVIDER PROFILE · NPI 1790880698

David HalvorsonM.D.

OtolaryngologyAlabaster, ALI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$4K

Peer benchmark

Total Medicare services vs. 141 Otolaryngology providers in AL — bottom quintile (cohort median 1,570).

PRESCRIBING · PART D · 2024

Total Rx claims

589

Beneficiaries

—

Total drug cost

$88K

Distinct drugs

Brand share

7.6%

Top prescribed drugs

Montelukast Sodium179 claims

Fluticasone Propionate128 claims

Azelastine Hcl38 claims

Omeprazole34 claims

Meclizine Hcl25 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$28

Payment records

By payment type

Food and Beverage$28

REFERRAL NETWORK

Where David Halvorson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
BAPTIST HEALTH SYSTEM, INC	62	166
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	33	60
NPI 1265437461	22	59
MCDANIEL, BENJAMIN	19	69
BRAWNER, STEPHEN	18	60
LAKANEN, KAREN	15	35
Angelia Brown Certified Registered Nurse Anesthetist (CRNA) · Alabaster, AL	15	34
Cynthia Walters Internal Medicine · Alabaster, AL	12	45
Daniel Allendorf Medical Oncology · Birmingham, AL	11	27

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history